Design and Methodology of the Korean Early Psychosis Cohort Study. 2017

Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.

The present study details the rationale and methodology of the Korean Early Psychosis Cohort Study (KEPS), which is a clinical cohort investigation of first episode psychosis patients from a Korean population. The KEPS is a prospective naturalistic observational cohort study that follows the participants for at least 2 years. This study includes patients between 18 and 45 years of age who fulfill the criteria for one of schizophrenia spectrum and other psychotic disorders according to the diagnostic criteria of DSM-5. Early psychosis is defined as first episode patients who received antipsychotic treatment for fewer than 4 consecutive weeks after the onset of illness or stabilized patients in the early stages of the disorder whose duration of illness was less than 2 years from the initiation of antipsychotic treatment. The primary outcome measures are treatment response, remission, recovery, and relapse. Additionally, several laboratory tests are conducted and a variety of objective and subjective psychiatric measures assessing early life trauma, lifestyle pattern, and social and cognitive functioning are administered. This long-term prospective cohort study may contribute to the development of early intervention strategies and the improvement of long-term outcomes in patients with schizophrenia.

UI MeSH Term Description Entries

Related Publications

Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
August 2023, Archives of Iranian medicine,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
May 2008, Pharmacoepidemiology and drug safety,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
March 2024, Biological psychiatry. Cognitive neuroscience and neuroimaging,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
April 2014, Tuberculosis and respiratory diseases,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
July 2011, Cephalalgia : an international journal of headache,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
February 2007, Acta psychiatrica Scandinavica,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
February 2007, Early intervention in psychiatry,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
January 2023, Frontiers in public health,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
April 2014, BMC public health,
Sung-Wan Kim, and Bong Ju Lee, and Jung Jin Kim, and Je-Chun Yu, and Kyu Young Lee, and Seung-Hee Won, and Seung-Hwan Lee, and Seung-Hyun Kim, and Shi Hyun Kang, and Young-Chul Chung
February 2022, BMJ open,
Copied contents to your clipboard!